530654 Sigma-Aldrichc-Rel Inhibitor, IT-603 - CAS 292168-90-2 - Calbiochem
A cell-permeable compound that directly and reversibly binds to c-Rel to change its conformation and blocks its DNA binding and transcriptional activity (IC₅₀ = 3 µM).
More>> A cell-permeable compound that directly and reversibly binds to c-Rel to change its conformation and blocks its DNA binding and transcriptional activity (IC₅₀ = 3 µM). Less<<MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
同义词: (5Z)-5-((5-Bromo-2-hydroxy-3-methoxyphenyl)methylidene)-2-sulfanylideneimidazolidin-4-one, (5Z)-5-(5-Bromo-2-hydroxy-3-methoxybenzylidene)-2-thioxo-4-imidazolidinone, IT603
Recommended Products
概述
| Replacement Information |
|---|
重要规格表
| CAS # | Empirical Formula |
|---|---|
| 292168-90-2 | C₁₁H₉BrN₂O₃S |
价格及供货情况
| 产品目录编号 | 库存情况 | 包装 | 数量 / 包装 | 价格 | 数量 | |
|---|---|---|---|---|---|---|
| 5.30654.0001 |
|
玻璃瓶 | 10 mg |
|
— |
| References | |
|---|---|
| References | Shono, Y., et al. 2014. Cancer Discovery 4, 578. |
| Product Information | |
|---|---|
| CAS number | 292168-90-2 |
| Form | Dark yellow powder |
| Hill Formula | C₁₁H₉BrN₂O₃S |
| Chemical formula | C₁₁H₉BrN₂O₃S |
| Reversible | Y |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | c-Rel |
| Purity | ≥97% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | Y |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| 产品目录编号 | GTIN |
| 5.30654.0001 | 04055977260410 |
Documentation
c-Rel Inhibitor, IT-603 - CAS 292168-90-2 - Calbiochem MSDS
| 职位 |
|---|
参考
| 参考信息概述 |
|---|
| Shono, Y., et al. 2014. Cancer Discovery 4, 578. |



